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Abstrak
Latar belakang: Pengobatan hiperkolesterolemia sering berlangsung seumur hidup sehingga menyebabkan 
penderita meninggalkan obat kimia dan memilih obat herbal. Penelitian ini merupakan uji klinik yang bertujuan 
untuk mengetahui khasiat dari formula jamu antikolesterol yang terdiri dari daun jati belanda,  daun jati cina, 
daun tempuyung, daun teh hijau, rimpang temulawak, rimpang kunyit dan herba meniran  dalam menurunkan 
kadar kolesterol darah sebagai bagian dari program Saintifikasi Jamu.  
Metode: Penelitian ini menggunakan metode kuasi eksperimental dengan desain pre dan post. Jumlah subjek 
50 pasien dengan hiperkolesterolemia ringan yang memenuhi kriteria inklusi. Penelitian dilakukan di Rumah 
Riset Jamu (RRJ) Hortus Medicus Tawangmangu pada bulan September sampai Desember 2014. Uji statistik 
yang digunakan adalah uji t berpasangan dengan bantuan program SPSS 16.
Hasil: Formula jamu antihiperkolesterol yang diminum setiap hari selama 28 hari mampu menurunkan rata-
rata kadar kolesterol plasma subjek dari 212.42 mg / dl menjadi 196.6 mg / dl. Uji t test berpasangan didapatkan 
hasil p<0,05 yang berarti ada perbedaan rerata kadar kolesterol sebelum dan sesudah pemberian jamu.
Kesimpulan: Formula jamu antihiperkolesterol mampu menurunkan kadar kolesterol plasma pasien 
dengan hiperkolesterolemia ringan pada pemberian selama 28 hari. (Health Science Journal of Indonesia 
2018;9(2):87-92)
Kata kunci: hiperkosterolemia, jamu, Saintifikasi jamu
Abstract
Background: Treatment of hypercholesterolemia often lasts a lifetime, therefore patients leave 
chemical drugs and choose herbal medicines. The aim of this clinical study is to evaluate the efficacy of 
antihiperkolesterol jamu formula consists of Guazuma ulmifolia leaves, Cassia senna leaves, Sonchus 
arvensis leaves, Camellia sinensis leaves, Curcuma xanthorrhiza rhizomes, Curcuma longa rhizomes and 
Phyllanthus niruri herbs  to lowering cholesterol plasma level  as part of Saintifikasi Jamu program.
Methods: This study was a quasi-experimental with pre and post test design. The total subjects were 50 
patients with mild hypercholesterolemia who met the inclusion criteria. The research took place at RRJ 
‘Hortus Medicus’ Tawangmangu between September to December 2014. The data were analyzed using a 
paired t-test with SPSS 16 software.
Results: Results showed jamu anticholesterol formula which is taken every day for 28 days lowered the 
mean of  cholesterol plasma level  of 212.42 mg / dl to 196.6 mg / dl. Paired t test at 95% confidence level 
acquired p value <0.05, showed that there is significant differences in the mean cholesterol level subjects 
before and after the study.
Conclusion: The administration of jamu antihypercholesterol formula for 28 days could reduce plasma 
cholesterol level  in subjects with mild hypercholesterolemia. (Health Science Journal of Indonesia 
2018;9(2):87-92)
Keywords: hypercholesterolemia, Jamu, Saintifikasi Jamu
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Hypercholesterolemia is a medical condition 
characterized by increased of cholesterol level in 
the blood exceeds the normal limit.1 Cholesterol has 
a soft structure, such as a candle, consisting of fat 
that can be produced by the body or derived from 
food.2 Cholesterol is produced in the liver, and has 
a function to build cell walls as well as a precursor 
of steroid hormones.3 Normally  cholesterol  plasma 
level is below 200 mg/dL, while the cholesterol 
level more than or equal to 200 mg/dL indicates 
hiperkolesterolemia (Table 1).1 
Table 1. Classification of Plasma Cholesterol Level.1
Total Cholesterol (mg/dl) Classification
<200 Normal
200-239 Borderline high
≥240 High
Hypercholesterolemia increases the risk of coronary 
heart diseases, cardiovascular diseases, and stroke 
through atherosclerosis process. 1,2 The high blood 
cholesterol levels are giving rise to a low-grade 
systemic inflammatory response in multiple vascular 
beds. Inflammation increases Reactive Oxygen 
Species (ROS) production that may damage cellular 
defence mechanisms leading to atherogenesis, 
protein damage and enzyme inactivation, with the 
final result of vascular dysfunction. 4,5
The cardiovascular disease (CVD) is the number one 
killer in the world especially in developing country.6 
World Health Organization reported about 1,7 million 
people died each year from CVD’s. It is estimated 
31% of all deaths world wide and more than 75% of 
CVD deaths occur in low income and middle income 
countries.7  Along with advancement of technology 
and change in modern lifestyles, an estimated number 
of patients with hypercholesterolemia will increase. 
According to Riset Kesehatan Dasar (RISKESDAS) 
in 2013 the prevalence of hypercholesterolemia 
in the Indonesian population aged 15 years and 
over was 35,9%.8 Hypercholesterolemia treatment 
becomes very important in order to reduce the risk 
of complications. The priority treatment for mild/ 
borderline high  of hypercholesterolemia (cholesterol 
values 200-239 mg/dl) is the lifestyle changes such 
as regular exercise, reducing intake of fatty foods, 
and last step is using drugs/ herbs that can lower 
cholesterol plasma level.2,9 
Hypercholesterolemia is a matabolic disorder that 
often require lifelong treatment. These conditions 
often make patients leave conventional treatment 
and chose herbal treatment.10 Based on data from 
the Rumah Riset Jamu ‘Hortus Medicus’ there are 
about 500 new cases of hypercholesterolemia during 
2013. Indonesia has some Jamu formulas that have 
empirically been used to lower blood cholesterol level. 
The potential of Jamu anticholesterol formula 
consists of Guazuma ulmifolia, Cassia senna, 
Sonchus arvensis, Camellia sinensis, Curcuma 
xanthorrhiza (C. xanthorrhiza), Curcuma longa 
(C. longa) and Phyllanthus niruri as alternative 
medicine that should be investigated. Preclinical 
study regarding this formula had been conducted by 
Saryanto et al in 2014 with the result administration 
of jamu anticholesterol formula infusion at dose 270 
mg / 200 gram body weight, 540 mg / 200 gram body 
weight and 1080 mg / 200 gram body weight in rats, 
previously given high-fat feed for 30 days causing a 
decrease in cholesterol respectively of 57 mg / dl , 
120 mg / dl and 121 mg / dl were lower than positive 
controls with the administration of simvastatin which 
decreased by 99 mg / dl and higher than negative 
control. The oral single dose of jamu formula used in 
this study does not cause toxic effects, with an LD50 
value greater than 5000 mg / Kgbb, cathegorized as 
Practical Non Toxic (PNT) or including non-toxic 
materials. Sub-chronic toxicity test showed that 
administration of jamu formula for 3 months did not 
resulting toxic effect or death in the rats. Neither of 
damage was found on the organ examination, so the 
jamu formula in the safe category were used.11,12 
The aim of this study is to evaluate the efficacy of the 
jamu anticholesterol formula in lowering cholesterol 
plasma level,  in term of  Saintifikasi Jamu program.
METHODS 
Plants Materials
The anticholesterol jamu were prepared and packaged 
by post harvest division of Medicinal Plant and 
Traditional Medicine Research and Development 
Center. One packaged for daily dosage contains 6 
gram Guazuma ulmifolia dried leaves, 1 gram Cassia 
sennae dried leaves, 6 gram Sonchus arvensis dried 
leaves , 5 gram  Camellia sinensis dried leaves, 5 
gram C. xanthorrhiza dried rhizomes, 4 gram C. longa 
dried rhizomes and  3 gram Philanthus niruri dried 
herbs. Raw materials used in this study had passed the 
quality control stages before packaged : determination 
of simplicia species, sortation to ensure simplicia is 
free from contaminants and several tests to ensure 
water level was less than 10%, total plate count, mold 
and yeast less than 10, no microbial pathogens found 
Vol. 9, No.2, December 2018 Jamu formula could reduce plasma cholesterol 89
in the simplicia and the aflatoxin count was not more 
than 30 parts per million.
Inclusion and Exclusion Criteria
Inclusion criteria were:  1. Women or men aged 25-
60 years, old or new patients with mild/borderline 
hypercholesterolemia (total cholesterol 200-239 mg/
dl), 2. The patient’s condition is stable evidenced 
by clinical examination, laboratory and ECG, 3. 
Patients were willing to follow the study/ follow-up 
schedule by signing the informed consent
Exclusion criteria were: 1. Pregnant or breastfeeding 
women (based recognition), 2. Patients taking the drug 
or other herbal ingredients which had an indication for 
lowering cholesterol and blood-thinning medications 
such as warfarin, digoxin 3. Patients with severe disease 
complications and gaastrointestinal conditions (eg ad van-
ced cancer / terminal, 2,3,4 NYHA heart failure, severe 
diabetes, severe hypertension, gastritis, ulcer pep ticum, 
Crohn’s disease and colitis.), 4. Patients have an allergies/ 
hypersensitivities to any component of test material.
Study Design
This research was a quasi experimental with pre-
post test design. Total sample were 50 patients with 
mild hypercholesterolemia who met the inclusion 
criteria at the Rumah Riset jamu (RRJ) ‘Hortus 
Medicus’ Medicinal Plant and Traditional Medicine 
Research and Development Center, Tawangmangu. 
The research was carried out between September 
to December 2014 with the ethical approval by 
The Ethic Commission of Health Research and 
Development Department, Health Ministry Republic 
of Indonesia (LB 02.01/5.2/KE 364/2014).
Sample size was determined using the following 
formula :13 
 
Sample size was 47,25 with an estimated 5% dropout, 
the total sample was 50 subjects.
The primary end point of this study was the decrease 
of average plasma cholesterol level below 200mg / 
dl and the secondary end point which expected was a 
reduced risk of atherosclerosis.
All subjects were examined on plasma cholesterol. After 
diagnosis of hypercholesterolemia was confirmed, 
each subject was given 7 packs of jamu anticholesterol 
formula for 7 days. Subjects should return once a week 
and drank jamu for 28 days. At the end of day 28, all 
subjects had a plasma cholesterol examined again.
Jamu Formula
All subjects were instructed to boil 1L of water every 
morning for 28 days, one pack of jamu formula was put 
into boiling water, wait 15 minutes and stop the boiling 
process. Filtered the water after it is cooling down, and 
take it each a glass two times a day after breakfast and 
dinner.
Statistical analysis
Data were analyzed using paired t test with the 
Statistical Product and Service Solutions (SPSS) 
program for window version 16.
RESULTS 
All fifty subjects completed the research for 28 days. 
More than 50% subjects are women, aged between 
41-60 and overweight. (table 2). Education and Age 
had correlations with cholesterol level (p<0,05) 
while gender, occupation, hypercholesterolemia 
history, Body Mass Index (BMI) and smoke habit 
had no correlation.
There are significant differences in reduction mean 
of subjects plasma cholesterol level before and after 
the study (p <0.05) (tabel 3).
A total of 35 subjects experienced a decrease in 
plasma cholesterol level, whereas 13 subjects 
experienced an increase in plasma cholesterol level, 
and 2 subjects  of study experience no change in 
plasma cholesterol level. The increase in the level 
of cholesterol at the end of the study can be caused 
by several factors: heredity, high-fat diet and lack 
of exercise. Hereditary factors play an important 
role in the occurrence of hypercholesterolemia. The 
hereditary hypercholesterolemia is more difficult 
to treat than lifestyle hypercholesterolemia. In 
this study there were no restrictions on diet for the 
subjects, only suggestion to reduce high fatty foods, 
so that the increase in the level of cholesterol in 13 
study subjects may occur due to excessive intake of 
fatty foods.14 In addition, lack of physical activity 
can also lead to increased cholesterol level  of 13 
study subjects.15
n is the sample size, Z is the level of confidence (75%), 
P is expected prevalence ( 30%) and d is presicion (5%)  
        Z2 P(1-P)
  n =--------------,
             d
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Table 2. The characteristics of Subjects
Variables Number of Subjects 
(n=50)
P
Gender
Men
Women
17 (34%)
33 (66%)
0,119*
Education
Elementary basic (Elementary 
and Junor High School
Middle (Senior High School)
High (Bachelor)
1 (2%)
27 (54%)
22 (44%)
0,000*
Occupation
House wifeves
Civil servants
Enterpreuners
Private employeers
16 (32%)
21 (42%)
10 (20%)
3 (6%)
0,390*
Hypercholesterolemia history
No history
< 1 year
1-5 year
7 (14%)
32 (64%)
11 (22%)
0,651*
Age 
31-40 y.o
41-50 y.o
51-60 y.o
12 (24%)
25 (50%)
13 (26%)
0,036*
Smoke habits
Yes
No 
2 (4%)
48 (96%)
0,640*
Body Mass Index (BMI)
Underweight
Normal
Overweight
Obese 
0 (0%)
22 (44%)
12 (24%)
16 (32%)
0,526*
*Chi Square test at the confidence level 95%
Table 3. The averages of  plasma cholesterol levels before 
and after ....
Variable D-0 D-28 P
Average of plasma cholesterol level 
(mg/dl)
212,42 196,6 0,000*
         *: paired t test with the level of confidence 95%
 Cholesterol plasma level of 28  subjects at the end 
of the 4th week became normal (<200 mg/dl), while 
22 subjects still had cholesterol level above 200 mg/
dl. There were 9 subjects that although experience 
decrease in cholesterol level  but still  above the 
normal level, the limited 28 days intervention could 
become the reason.
Administration of antikolesterol jamu formula for 28 
consecutive days was relatively safe for the liver and 
kidneys of the subjects, indicated by the absence of 
significant changes in the levels of Serum Glutamic 
Piruvic Transaminase (SGPT), Serum Glutamic 
Oxaloacetic Transaminase, Ureum and Creatinine. A 
full report on the safety of this jamu formula will be 
written in another article.    
DISCUSSIONS
The prevalence of hypercholesterolemia in Indonesia 
is indeed higher in women, namely 14.5% while in 
men 8.6%. 14,16 Subject ages were in the range of 30-
60 years, none of subjects under 30 years old. This is 
consistent with the theory that increasing age is one 
of the risk factors for hypercholesterolemia.17  The 
majority of subject education is secondary and high 
education. This plays a role in treatment behavior. 
Higher education encourages a person to be more 
curious about his health condition. Usually mild 
hypercholesterolemia is asymptomatic and  often 
be found incidentally on routine health checks. The 
BMI 28 subjects were in the category of overweight 
and obese. As we all know being overweight is a 
predisposing factor for hypercholesterolemia.17
According to our knowledge, there are no similar 
study to this clinical study ever published. However, 
the scientific articles related to the safety and 
efficacy of each constituent plant in lowering plasma 
cholesterol invivo have been widely found.
Aqueous extract of Guazuma ulmifolia leaves 
contains tannin, flavonoids and saponin.18 Aqueous 
extract at a dose of 50 mg/kg bw can lower total 
cholesterol and Low Density Lipid (LDL) level 
significantly compared control.19  Mucilage in Jati 
belanda  can swell in the stomach so that pressing 
appetite. Alkaloids in Jati belanda has the activity in 
inhibiting pancreatic lipase enzyme that  hydrolyze 
fat.10 Dried extract of Jati belanda leaves doses of 
2, 4, and 8 g/kgbw that administered in male mice 
once a day for 3 months did not increase the level 
of creatine and plasma urea and an average diameter 
size of the rat kidney glomerulus.18,19 This suggests 
that long-term administration Jati belanda leaves 
does not disturb the function of kidney.20,21 
Cassia senna is a medicinal plant that has been 
known throughout the world. Society of India 
and the Middle East since long ago use Cassia 
senna to treat hemorrhoids, as a laxative, colon 
cleansing, helps get rid of all the toxins in the 
body, and to reduce body weight.22 In Indonesia 
Cassia senna leaves commercially sold in the form 
of tea bags or dried leaves with claims of efficacy 
to reduce body weight, laxative and lowering 
plasma cholesterol. Cassia sennae leaves contain 
hydroxyanthracene glycosides, with the derivate are 
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sennosides (BO-linked glycosides) has the effect of 
laxative. Sennosides are not absorbed in the upper 
intestine, and will be changed by bacteria in the large 
intestine becomes metabolically active rheinanthrone. 
Rheinanthrone would increase the motility of the colon, 
so shortening the transit time of food in the colon.23 
Cassia sennae leaves also contain flavonoids that can 
inhibit pancreatic lipase enzyme.22 Dose of sennosides 
up to 500mg/kgbw given to dogs for 4 weeks showed 
no toxic effects, as well as the dose to 100 mg/kg in rats 
during administration of 6 months.23
Camellia sinensis leaves contain polyphenols 
(catechins and flavonoids), alkaloids, volatile oil, 
polysaccharides and amino acid.24,25 Catechins in tea 
can lowering  total cholesterol and Low Density Lipid 
level in blood plasma. This is associated with the 
increasing of body metabolism. Epigallocathecin-3-
gallate (EGCG) in green tea stimulate thermogenesis 
and fat oxidation which has implications for body 
weight loss EGCG inhibits the activity of acetyl 
CoA carboxylase in fatty acid biosynthesis cycle, 
hence reducing the accumulation of triacylglycerol 
(triglycerides) in fat tissue.24,26,27 
Sonchus arvensis leaves contain kaempferol, 
quercetin, orientin, rutin, catechin and miristisin.28 
Indonesia community since long ago have been 
using tempuyung to treat kidney stones and lowering 
plasma cholesterol.29 It is rich in polyphenols, which 
have antioksidan activity.28 Empirically tempuyung 
leaf infusion has used to lower plasma cholesterol 
level.21 Studies in mice, showed the ethanol extract 
of Sonchus arvensis leaves with doses up to 1.000 
mg/kg proved to be safe and efficacious to lowering 
plasma cholesterol.30
Curcuma xanthorhizza rhizomes well known 
as temulawak and Curcuma longa rhizomes or 
turmeric or kunyit in bahasa has been used by local 
community in Indonesia as traditional remedy since 
centuries. Temulawak contains curcuminoid fraction 
which had been proven can reduce cholesterol in 
hypercholesterol rats through inhibition of  4 gene 
related oxidative stress expression CD44, ICAM-
1, iNOS, and LOX-1.31 Based on the invivo study, 
supplementation of turmeric extract in rats fed 
with high-cholesterol diet significantly increased 
the expression of cholesterol 7 α-hydroxylase, 
hemeoxygenase 1, and low-density lipoprotein 
receptors as well as decreased in 3-hydroxy-3-methyl-
glutarylCoA reductase level when compared with 
rats fed a normal or high-cholesterol diet, showing 
that turmeric could prevents hypercholesterolemia 
and fatty liver formation by the modulation of 
expressions of enzymes that are important to 
cholesterol metabolism.32  
Hydro-alcoholic extract of leaves of Phyllanthus 
niruri in India known as Phyllanthus amarus 
Schumach  possessed  significant hypolipidemic 
activity at doses 300 and 500 mg/kg in cholesterol 
diet induced hyperlipidemia rats. The extract contain 
of alkaloids, flavonoids, saponins and tannins. 
Saponin was known to elicit serum cholesterol 
lowering activity. 33
In conclusion, administration of antikolesterol 
Jamu formula for 28 days significantly lowered 
plasma cholesterol levels in study subjects with mild 
hypercholesterolemia. 
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